ACCORD-2 Phase 3 trial in Alzheimer’s disease agitation achieves primary endpoint compared to placebo (p=0.001, time to relapse)ACCORD-2 Phase 3 ...

Axsome Therapeutics (AXSM) announced the completion of its Phase 3 clinical program evaluating AXS-05 a novel, oral, investigational NMDA ...

For the holiday season, the Western New York Chapter of the Alzheimer’s Association has the following gift ideas for individuals living in the early, middle and late stages of Alzheimer’s disease, as ...

Spray-on trainers, a water-filtering bottle cap and inflatable self-defence devices for protestors feature in our roundup of the most impactful product designs from 2024. This year saw designers ...

The top gifts this holiday season might not be the best fit for everyone, especially those who have Alzheimer’s disease. Seven million Americans are living with the disease, according to the ...

Many people with Alzheimer's disease can still care for their own needs to various extents. Caring for yourself as much as possible is essential for maintaining your cognitive abilities. You can apply ...

Early detection is vital to treating Alzheimer’s disease — and AI could ... The state’s age-appropriate design law, which would require tech companies to consider kids’ safety and privacy ...

The darlings of the weight loss and diabetes spaces, GLP-1 receptor agonists have shown promise against Alzheimer’s in recent studies—with Phase III results expected next year from Novo Nordisk. Data ...

So who is the Titleist golfer? The simple answer is that Titleist designs golf clubs for everybody. Of course, every company that makes golf clubs would say the same thing but when you dig a little ...